11E10
11E10
11E10
11E10
11E10 ANTIBODY
11E10 ANTIBODY
11E10 ANTIBODY
11E10 ANTIBODY
11E10 ANTIBODY
11E10 HEAVY CHAIN VARIABLE REGION
11E10 MOUSE HYBRIDOMA ANTIBODY
13C4
13C4 ANTIBODY
13C4 ANTIBODY
13C4 ANTIBODY
13C4 ANTIBODY
13C4 HEAVY CHAIN PCR PRODUCT
13C4 MOUSE HYBRIDOMA ANTIBODY
5TH EDITION
ABI
ABI
ATCC
ATCC
ADDITIONAL FEATURE
AFLIII
AFLIII RESTRICTION SITE
AFLIII RESTRICTION SITE
AFLIII SITE
ANTIBODY
ANTIBODY
ANTIBODY PRODUCTION
ANTIBODY PRODUCTION
ANTIBODY PRODUCTION
B. ANTISERA NEUTRALIZATION ASSAY
B. ASSAY
B. ASSAY
ANTIBODY PRODUCTION B. ASSAY
ANTIBODY PRODUCTION B. ASSAY
B. PROTECTION
B. SUBCLONING
B2F1
BAMHI/NHEI
BETHESDA MD
BGLII/NHEI
BGLII/NHEI FRAGMENT
BSTBI
BSTBI
BSTBI/ECORV
CD-1 MOUSE
CD-1 MOUSE
CDR REGION
COMPLEMENTARITY DETERMINING REGIONS
COMPLEMENTARITY DETERMINING REGIONS
COMPLEMENTARITY DETERMINING REGIONS
COMPLEMENTARITY DETERMINING REGIONS
COMPLEMENTARITY DETERMINING REGIONS
COMPLEMENTARITY DETERMINING REGIONS
CN
CRL
CRL
CANCER RESEARCH
CELLTECH
CRUDE STX1
CRUDE STX1 TOXIN
DNA
DNA
DNA CONSENSUS SEQUENCE
DNA CONSENSUS SEQUENCE
DNA FRAGMENT LIGATION
DNA SEQUENCE
DNA SEQUENCE
DNA SEQUENCE DETERMINATION
DNA SEQUENCE DETERMINATION
PLASMID DNA SEQUENCE
PLASMID DNA SEQUENCE
DNA SEQUENCING
DAVIE FL
E. COLI
ENTEROHEMORRHAGIC ESCHERICHIA COLI
ENTEROHEMORRHAGIC ESCHERICHIA COLI
ENTEROHEMORRHAGIC ESCHERICHIA COLI
ENTEROHEMORRHAGIC ESCHERICHIA COLI
EHEC DIARRHEA
EHEC INFECTION
EHEC TREATMENT
EHEC-MEDIATED HUS
ECORI
ECORI
ECORI
ECORI/NOTI FRAGMENT
ECORI/NOTI FRAGMENT
ECORV/BSTBI DIGESTED
ECORV/BSTBI DIGESTED
ECORV/BSTBI FRAGMENT
ECORV/BSTBI FRAGMENT
EUR
EXPRESSION VECTOR
EXPRESSION VECTOR
G418
GI TRACT
HAMA RESPONSE
HAMA RESPONSE
HEMORRHAGIC COLITIS
HEMORRHAGIC COLITIS
HEMOLYTIC UREMIC SYNDROME
HEMOLYTIC UREMIC SYNDROME
HEAVY CHAIN PLASMID CLONE
CONTAINING DNA INSERT HEAVY CHAIN PLASMID CLONE
HUMANIZED MONOCLONAL ANTIBODY
HUMANIZED MONOCLONAL ANTIBODY
HUMANIZED MOUSE ANTIBODY
INV
IGD
IGE
IGG
IGG
IGG1
IGG1
IGG1
IGG1-KAPPA
IGG1-KAPPA
IGG2
IGG3
IGG4
IMMUN
IMMUNIZATION
IMMUNOLOGICAL INTEREST
INJECTION
INVITROGEN
INVITROGEN
INVITROGEN
J. CANCER
LIGATION
LIGATION
PCR FRAGMENT LIGATION
PCR FRAGMENT LIGATION
LIGHT CHAIN CANDIDATE CLONE
LOBUGLIO
NSO
NSO
NEOMYCIN RESISTANCE
NEOMYCIN RESISTANCE
NEUTRALIZATION
CYTOTOXIC ACTIVITY NEUTRALIZATION
NEW ENGLAND BIOLAB
NEW ENGLAND BIOLAB
NEW ENGLAND BIOLAB
NEW ENGLAND BIOLAB
NEW ENGLAND BIOLAB
NEW ENGLAND BIOLAB
NRUI/ECORI DIGESTED
NRUI/ECORI FRAGMENT
NRUI/ECORI FRAGMENT
ORAL INFECTION
P.N
PCR AMPLIFICATION
PCR AMPLIFICATION
PCR FRAGMENT
PCR FRAGMENT
PCR PRODUCT
PCR PRODUCT
PLASMID CLONE
CONTAINING DNA INSERT PLASMID CLONE
POSITIVE CLINICAL RESPONSE
PROMEGA
QIAGEN
QIAGEN
QIAGEN
QIAQUICK PCR PURIFICATION COLUMN
QIAQUICK PCR PURIFICATION COLUMN
QIAQUICK PCR PURIFICATION COLUMN
RT-PCR
RT-PCR
ROCKVILLE MD
SEQ ID
SEQ ID
SEQ ID
SEQ ID
SEQ ID
SEQ ID
SP2
SP2
SP20 CELL LINE
SP20 MYELOMA CELL
SHIGA
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN FAMILY
SHIGA TOXIN FAMILY
SHIGA TOXIN INDUCED DISEASE
SHIGA TOXIN INDUCED DISEASE
SHIGA TOXIN INDUCED DISEASE
SHIGA TOXIN NEUTRALIZATION
SHIGA TOXIN PROTEIN
SHIGA TOXIN PROTEIN
SHIGA TOXIN PROTEIN
SHIGA TOXIN PROTEIN
SHIGA TOXIN-INDUCED DISEASE
SHIGA TOXIN-PRODUCING BACTERIAL INFECTION
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGELLA DYSENTERIAE
SHIGELLA DYSENTERIAE-TYPE
SIMILAR RESULT
STERLING VA
STINSON JEFFREY R.
STX
STX
SHIGELLA DYSENTERIAE-TYPE STX
STX TYPE
STX1
STX1
STX1 TOXIN
STX1 TOXIN CHALLENGE
STX2
STX2
STX2 GROUP
STX2 TOXIN
STX2-PRODUCING EHEC STRAIN
STX2-VARIANT
STX2-VARIANT TOXIN
T/A CLONING VECTOR
T/A STYLE CLONING VECTOR
T/A STYLE CLONING VECTOR
T/A STYLE CLONING VECTOR
TRANSFECTION
TRANSFECTION
VARIABLE REGION
VERO CELL CYTOTOXICITY ASSAY
VERO CELL NEUTRALIZATION ASSAY
VOL
WESTON FL
WIZARD PCR PURIFICATION SYSTEM
XL1 BLUE CELL
ABBREVIATION STX
ABILITY
ACID CONSENSUS SEQUENCE
ACID CONSENSUS SEQUENCE
ADDITION
ADDITION
ADDITION
ADDITION
ADMINISTERED MURINE ANTI-TNF
ADMINISTRATION
AMINOGLYCOSIDE PHOSPHOTRANSFERASE
ANTI-SHIGA TOXIN ANTIBODY
ANTI-STX
ANTI-STX2 ANTIBODY
ANTI-STX2 ANTIBODY
ANTI-MOUSE ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY CHAIN
ANTIBODY CHAIN
ANTIBODY EXPRESSION CASSETTE
ANTIBODY PREPARATION PROCESS
ANTIBODY VARIABLE REGION CODING INFORMATION
ANTIGEN
ANTIGEN BINDING
APPARATUS
ARTIFACT
ANTIBODY PREPARATION PROCESS ARTIFACT
ASPECT
ASPECT
ASPECT
ASPECT
ASSAY
BACTERIAL VECTOR
BACTERIAL VECTOR
DNA SEQUENCE DETERMINATION BACTERIAL VECTOR
DNA SEQUENCE DETERMINATION BACTERIAL VECTOR
BP
BP
BP
BP
BP
BP
BP
BP
BP
CDNAS ANALYZED
CDNAS ANALYZED
CARBOXY-TERMINAL END
CELL TRANSFECTION
CHAIN PCR PRODUCT
CHAIN PCR PRODUCT
CHAIN PCR PRODUCT
CHAIN PCR PRODUCT
CHAIN PCR PRODUCT
CHAIN PCR PRODUCT
CHAIN EXPRESSION VECTOR
REQUIRED DNA FRAGMENT LIGATION CHAIN EXPRESSION VECTOR
CHAIN FRAGMENT
CHAIN INSERT
CHAIN MOLECULE
CHAIN MOLECULE
CHAIN MOLECULE
CHAIN MOLECULE
CHAIN PLASMID CLONE
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
CHAIN VARIABLE DOMAIN
ANTIBODY CHAIN VARIABLE DOMAIN
ANTIBODY CHAIN VARIABLE DOMAIN
ANTIBODY CHAIN VARIABLE DOMAIN
ANTIBODY CHAIN VARIABLE DOMAIN
ANTIBODY CHAIN VARIABLE DOMAIN
ANTIBODY CHAIN VARIABLE DOMAIN
MURINE 11E10 ANTIBODY CHAIN VARIABLE DOMAIN
MURINE 11E10 ANTIBODY CHAIN VARIABLE DOMAIN
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION PCR PRODUCT
11E10 CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VARIABLE REGION
CHAIN VECTOR
CHAIN VECTOR CUT
CHIMERIC HUMAN/MOUSE MONOCLONAL ANTIBODY
CHIMERIC HUMAN/MOUSE MONOCLONAL ANTIBODY
CHIMERIC KAPPA
CHIMERIC MOUSE/HUMAN ANTIBODY MOLECULE
CHIMERIC MOUSE/HUMAN ANTIBODY MOLECULE
CHIMERIC VERSION
CHIMERIC VERSION
11E10 MOUSE HYBRIDOMA ANTIBODY CHIMERIC VERSION
13C4 MOUSE HYBRIDOMA ANTIBODY CHIMERIC VERSION
CLINICIAN
CLONE
CLONING
CLONING
CLONING STRATEGY
COLI STRAIN
COMPLEMENTARITY
COMPLEMENTARITY
DETERMINING REGION COMPLEMENTARITY
DETERMINING REGION COMPLEMENTARITY
COMPLICATION
COMPLICATION
COMPLICATION
ENTEROHEMORRHAGIC ESCHERICHIA COLI COMPLICATION
COMPOUND
COMPOUND
COMPOUND
CONSIDERATION
SPECIFICATION CONSIDERATION
CONSTRUCTION
CONSTRUCTION
CONSTRUCTION
CONSTRUCTION
MAMMALIAN EXPRESSION VECTOR CONSTRUCTION
PLASMID PJRS311 CONSTRUCTION
PLASMID PJRS315 CONSTRUCTION
CONTAINING DNA INSERT
CONTAINING DNA INSERT
CONTAINING INSERT
CONTAINING INSERT
CYTOTOXIC ACTIVITY
DAYCARE COHORT
DERIVATIVE
DESIGNATED PACE1
DESIGNATED PACE4
DETERMINING REGION
DETERMINING REGION
DEVELOPED ANTI-MURINE ANTIBODY RESPONSE
DIAGNOSTIC RESTRICTION ENZYME DIGEST
DIAGNOSTIC RESTRICTION ENZYME DIGEST
DRUG G418
DYE-TERMINATOR SEQUENCE REACTION
DYE-TERMINATOR SEQUENCE REACTION
EDEMA
EPSILON
EXPRESSION PLASMID
EXPRESSION VECTOR
EXPRESSION VECTOR
EXPRESSION VECTOR
EXPRESSION VECTOR
EXPRESSION VECTOR
FINAL CONSENSUS DNA SEQUENCE
FINAL CONSENSUS DNA SEQUENCE
FINAL CONSENSUS DNA SEQUENCE
FINAL CONSENSUS DNA SEQUENCE
FINAL CONSENSUS DNA SEQUENCE
FINAL CONSENSUS SEQUENCE
FINAL EXPRESSION VECTOR CLONE
FORMULATION
GAMMA
GAMMA
GAMMA
GAMMA
GAMMA
HEMOLYTIC UREMIC SYNDROME
HEMOLYTIC UREMIC SYNDROME
HEMORRHAGIC COLITIS
HEMORRHAGIC COLITIS
HOST CELL
HOST CELL
HYBRIDOMA CELL LINE
HYBRIDOMA CELL LINE
IDENTIFICATION
MURINE MONOCLONAL ANTIBODY IDENTIFICATION
IMMUNIZATION
IMMUNOLOGICAL
IMMUNOREACTIVE
IMMUNOSPECIFICITY
INCREASING TOXIN RELEASE
INDUCED DISEASE
INFECTION
INFECTIOUS COMPLICATION
INSTRUCTION
INSTRUCTION
INSTRUCTION
KAPPA
KAPPA
KAPPA
KAPPA
KAPPA
KAPPA EXON
KAPPA EXON
LAMBDA
LETHAL ORAL DOSE
ENTEROHEMORRHAGIC ESCHERICHIA COLI LETHAL ORAL DOSE
LIFE-THREATENING SEQUELA
LIFE-THREATENING SEQUELA HUS
LIGATION REACTION
LIGATION REACTION
LYSATE
MAMMALIAN CELL
MAMMALIAN CELL
MAMMALIAN CELL
MAMMALIAN CELL
MAMMALIAN EXPRESSION PLASMID VECTOR
MAMMALIAN EXPRESSION PLASMID VECTOR
MAMMALIAN EXPRESSION VECTOR
MAMMALIAN EXPRESSION VECTOR
MAMMALIAN EXPRESSION VECTOR
MANUFACTURER
MANUFACTURER
MANUFACTURER
MANUFACTURER
MANUFACTURER
MANUFACTURER
MANUFACTURER
MANUFACTURER
MANUFACTURER
MEDICAL ART
MG/KG BODY WEIGHT
MG/KG BODY WEIGHT
MICROLITER
MODIFICATION
MOLAR RATIO
MOLAR RATIO
MONOCLONAL
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
13C4 MONOCLONAL ANTIBODY
DEVELOPED ANTI-MURINE ANTIBODY RESPONSE MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL HUMANIZED ANTIBODY
MONOCLONAL HUMANIZED ANTIBODY
MOUSE 13C4 ANTIBODY
MOUSE J REGION/KAPPA INTRON FRAGMENT
MOUSE J REGION/KAPPA INTRON FRAGMENT
MOUSE ANTIBODY
MOUSE KAPPA INTRON REGION
MOUSE KAPPA INTRON REGION
MOUSE SPLENOCYTE
MOUSE SPLENOCYTE
MOUSE/HUMAN CHIMERIC KAPPA
MU
MULTI-UNIT BACTERIAL PROTEIN
MULTI-UNIT BACTERIAL PROTEIN
MURINE
MURINE 11E10 ANTIBODY
MURINE 11E10 ANTIBODY
MURINE MONOCLONAL ANTIBODY
MUTAGENESIS STEP
MUTAGENESIS STEP
MYELOMA CELL LINE
NEGATIVE CONTROL
NEO
NON-HUMAN ANTIBODY
NON-HUMAN SOURCE
NON-HUMAN SOURCE
NON-SPECIFIC BACKGROUND BINDING
NORMAL LETHAL TOXIN DOSE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID MOLECULE
NUCLEIC ACID SEQUENCE
NUCLEIC ACID SEQUENCE
NUCLEIC ACID SEQUENCE
NUCLEIC ACID SEQUENCE
SEQ ID NUCLEIC ACID SEQUENCE
SEQ ID NUCLEIC ACID SEQUENCE
SEQ ID NUCLEIC ACID SEQUENCE
SEQ ID NUCLEIC ACID SEQUENCE
NURSING HOME
OLIGONUCLEOTIDE SEQUENCE
OLIGONUCLEOTIDE
ORDINARY SKILL
PACE1
PACE1
PACELC
PCR-2
PJRS315
PJRS315
PSUN15
PASSIVE PREVENTATIVE MEASURE
PATHOGENIC E. COLI
PATHOGENIC BACTERIUM
PHARMACEUTICAL COMPOSITION
PHARMACEUTICAL COMPOSITION
PHARMACOLOGICAL APPROACH
PLASMID
PLASMID CLONE
PLASMID PACE4
PLASMID PJRS311
PLASMID PJRS315
PLASMID PJRS315
PLASMID PSUN15
PLASMID
PLASMID
POLYCLONAL
POSITIVE STOOL SAMPLE TEST
SHIGA TOXIN POSITIVE STOOL SAMPLE TEST
POST-TRANSCRIPTIONAL
POST-TRANSCRIPTIONAL
POTENTIAL PATIENT GROUP
PREPARATION
PROTEINACEOUS STRUCTURE
PSEUDOGENE
PSEUDOGENE
KAPPA PSEUDOGENE
KAPPA PSEUDOGENE
PSEUDOGENE TRANSCRIPT
PSEUDOGENE TRANSCRIPT
PUBLICIZED STUDY
REGION EXON
REGION EXON
REQUIRED DNA FRAGMENT LIGATION
RESTRICTION SITE
RESTRICTION SITE
RESTRICTION SITE
RESTRICTION SITE
RESULTING PLASMID
RESULTING VECTOR CLONE
RISK INDIVIDUAL
RODENT
ROUTINE MEDICAL PROCEDURE
ROUTINE SKILL
SCHEMATIC REPRESENTATION
SELECTABLE MARKER
SELECTABLE MARKER
SELECTABLE MARKER
SELECTABLE MARKER
VECTOR SELECTABLE MARKER
VECTOR SELECTABLE MARKER
TRANSFECTION SELECTABLE MARKER
TRANSFECTION SELECTABLE MARKER
MAMMALIAN CELL TRANSFECTION SELECTABLE MARKER
MAMMALIAN CELL TRANSFECTION SELECTABLE MARKER
SEQUENCING INSTRUMENT
SEQUENCING INSTRUMENT
SHIGA TOXIN
INDUCED DISEASE SHIGA TOXIN
SPECIFICATION
SPECIFICATION
SPECIFICATION
SPECIFICATION
STRUCTURAL FEATURE
SUBCLASS
SUBCLASS
SUBSTITUTION
SUCROSE SOLUTION
SYMPTOM
SYSTEMIC EFFECT
TOXIN SYSTEMIC EFFECT
TKMC226
TERM SHIGA TOXIN
TERMINAL END
THERAPEUTIC AGENT
THERAPEUTIC EFFECTIVENESS
THROMBOCYTOPENIA
THROMBOTIC THROMBOCYTOPENIC PURPURA
TOXIN
TOXIN
TOXIN
TOXIN
TOXIN NEUTRALIZATION
TOXIN PROTEIN
TOXIN/ANTIBODY PAIR
TOXOID
TRANSCRIPTION
TRANSCRIPTION
TRANSCRIPTIONAL PROMOTER
TRANSCRIPTIONAL PROMOTER
TRANSFECTANT
TRANSFECTION
TRANSFECTION
TRANSFECTION
TRANSFECTION
TREATMENT REGIMEN
TREATMENT REGIMEN
TUMOR NECROSIS FACTOR
VARIABLE REGION
VECTOR
VECTOR
VECTOR
VECTOR
VECTOR
VECTOR
VECTOR CUT
MOLAR RATIO VECTOR
MOLAR RATIO VECTOR
VECTOR RESULT
ENTEROHEMORRHAGIC ESCHERICHIA COLI
EHEC
HEMORRHAGIC COLITIS
HC
HEMOLYTIC UREMIC SYNDROME
HUS
COMPLEMENTARITY DETERMINING REGIONS
CDRS
COMPLEMENTARITY DETERMINING REGIONS
CDRS
PHOSPHATE BUFFERED SALINE
PBS
HYBRIDOMA
HEAVY CHAIN PCR PRODUCT
CHAIN PCR PRODUCT
PCR
HYBRIDOMA
EDITION
PRODUCTION
PRODUCTION
PRODUCTION
PROTECTION
SUBCLONING
RESEARCH
STX1
CRUDE STX1
STX1
SEQUENCE DETERMINATION
SEQUENCE DETERMINATION
SEQUENCING
FL
COLI
INFECTION
TREATMENT
HUS
EXPRESSION
EXPRESSION
RESPONSE
RESPONSE
HEAVY CHAIN PLASMID
PLASMID
IMMUNOLOGICAL
INTEREST
LIGHT CHAIN CANDIDATE
RESISTANCE
RESISTANCE
INFECTION
AMPLIFICATION
AMPLIFICATION
QIAQUICK PCR PURIFICATION
PCR
QIAQUICK PCR PURIFICATION
PCR
QIAQUICK PCR PURIFICATION
PCR
CELL LINE
SP20 MYELOMA
MYELOMA
SHIGA
SHIGA
SHIGA
SHIGA
SHIGA
SHIGA
SHIGA
SHIGA
SHIGA
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA
SHIGA
SHIGA
TOXIN NEUTRALIZATION
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA TOXIN
SHIGA
SHIGA
SHIGA
SHIGA
DYSENTERIAE
SHIGELLA
DYSENTERIAE-TYPE
VA
STX
STX1
TOXIN CHALLENGE
STX2
STX2-PRODUCING EHEC
EHEC
STX2-VARIANT
CLONING VECTOR
CLONING
CLONING
CLONING
VARIABLE
FL
PCR
STX
ACID CONSENSUS
ACID CONSENSUS
MURINE
PHOSPHOTRANSFERASE
ANTI-MOUSE
VARIABLE REGION CODING INFORMATION
REGION CODING INFORMATION
CARBOXY-TERMINAL
TRANSFECTION
PCR PRODUCT
PCR
PCR PRODUCT
PCR
CHAIN PCR
PCR
CHAIN PCR
PCR
CHAIN PCR
PCR
CHAIN PCR
PCR
CHAIN EXPRESSION
CHAIN PLASMID
PLASMID
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
VARIABLE DOMAIN
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
VARIABLE REGION PCR PRODUCT
REGION PCR PRODUCT
PCR
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
CHAIN VARIABLE
VECTOR CUT
CHIMERIC
KAPPA
CHIMERIC
MOUSE/HUMAN
CHIMERIC
MOUSE/HUMAN
STRAIN
CONTAINING DNA
DNA
CONTAINING DNA
DNA
PACE1
PACE4
G418
EXPRESSION
PLASMID
EXPRESSION
EXPRESSION
EXPRESSION
EXPRESSION
EXPRESSION
FINAL CONSENSUS
DNA
FINAL CONSENSUS
DNA
FINAL CONSENSUS
DNA
FINAL CONSENSUS
DNA
FINAL CONSENSUS
DNA
FINAL CONSENSUS
EXPRESSION VECTOR CLONE
VECTOR CLONE
UREMIC SYNDROME
UREMIC SYNDROME
HOST
CELL LINE
CELL LINE
TOXIN RELEASE
KAPPA
EXON
KAPPA
EXON
ORAL DOSE
SEQUELA
SEQUELA HUS
MAMMALIAN EXPRESSION
MAMMALIAN
PLASMID
MAMMALIAN EXPRESSION PLASMID
MAMMALIAN EXPRESSION
PLASMID
MAMMALIAN EXPRESSION
MAMMALIAN EXPRESSION
MAMMALIAN EXPRESSION
BODY WEIGHT
BODY WEIGHT
RATIO
13C4
J
INTRON
J
INTRON
KAPPA INTRON REGION
KAPPA
KAPPA INTRON REGION
KAPPA
MOUSE/HUMAN
CHIMERIC KAPPA
CHIMERIC
11E10
11E10
MYELOMA CELL
CELL LINE
CONTROL
NON-HUMAN
NON-HUMAN
SOURCE
NON-HUMAN
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
NUCLEIC ACID
PREVENTATIVE MEASURE
E. COLI
COMPOSITION
PLASMID
PACE4
PJRS311
PJRS315
PJRS315
PLASMID
PSUN15
POTENTIAL PATIENT
TRANSCRIPT
TRANSCRIPT
EXON
EXON
DNA
RESTRICTION
RESTRICTION
RESTRICTION
RESTRICTION
PLASMID
VECTOR CLONE
RISK
REPRESENTATION
MARKER
MARKER
MARKER
MARKER
SHIGA
TERM
SHIGA
THROMBOCYTOPENIC PURPURA
NEUTRALIZATION
TRANSCRIPTIONAL
TRANSCRIPTIONAL
TREATMENT
TREATMENT
NECROSIS FACTOR
VARIABLE
CUT
